Lead In Treatment with PEG Interferon and Ribavirin is Useful before Initiating Telaprevir in Liver Transplant Recipients with Recurrent Hepatitis C

被引:0
|
作者
Nair, Satheesh [1 ,2 ]
Satapathy, Sanjaya [1 ,2 ]
Waters, Bradford [1 ,2 ]
机构
[1] Univ Tennessee, Ctr Hlth Sci, Transplant Inst, Methodist Transplant Inst, Memphis, TN 38163 USA
[2] Vet Affairs Hosp, Memphis, TN USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1755
引用
收藏
页码:1052A / 1052A
页数:1
相关论文
共 50 条
  • [31] Aplastic anemia and severe pancytopenia during treatment with peg-interferon,ribavirin and telaprevir for chronic hepatitis C
    Sabela Lens
    Jose L Calleja
    Ana Campillo
    Jose A Carrión
    Teresa Broquetas
    Christie Perello
    Juan de la Revilla
    Zoe Mari?o
    María-Carlota Londo?o
    Jose M Sánchez-Tapias
    álvaro Urbano-Ispizua
    Xavier Forns
    World Journal of Gastroenterology, 2015, (17) : 5421 - 5426
  • [32] Outcome of Treatment With Pegylated Interferon and Ribavirin in Heart Transplant Recipients With Chronic Hepatitis C
    Durante-Mangoni, E.
    Ragone, E.
    Pinto, D.
    Iossa, D.
    Covino, F. E.
    Maiello, C.
    Utili, R.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (01) : 299 - 303
  • [33] Peginterferon and Ribavirin for Treatment of Recurrent Hepatitis C Disease in HCV- HIV Coinfected Liver Transplant Recipients
    Terrault, N.
    Reddy, K. R.
    Poordad, F.
    Curry, M.
    Schiano, T.
    Johl, J.
    Shaikh, O.
    Dove, L.
    Shetty, K.
    Millis, M.
    Schiff, E.
    Regenstein, F.
    Barnes, D.
    Barin, B.
    Peters, M.
    Roland, M.
    Stock, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (05) : 1129 - 1135
  • [34] Interferon-α and ribavirin for the treatment of recurrent hepatitis C after liver transplantation
    de Vera, ME
    Smallwood, GA
    Rosado, K
    Davis, L
    Martinez, E
    Sharma, S
    Stieber, AC
    Heffron, TG
    TRANSPLANTATION, 2001, 71 (05) : 678 - 686
  • [35] Treatment with combination peginterferon alfa-2b and ribavirin of recurrent hepatitis C in liver transplant recipients nonresponsive to interferon alfa-2b and ribavirin
    Samanta, A
    Mandalapu, A
    Fisher, A
    Wilson, D
    de la Torre, A
    Klein, KM
    Koneru, B
    GASTROENTEROLOGY, 2005, 128 (04) : A455 - A456
  • [36] Nonresponders of interferon/ribavirin treatment for recurrent hepatitis C following liver transplantation
    Smallwood, GA
    Davis, L
    Connor, K
    Martinez, E
    Stieber, AC
    Heffron, TG
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (04) : 1476 - 1477
  • [37] IMPACT OF PEGYLATED INTERFERON AND RIBAVIRIN TREATMENT ON GRAFT SURVIVAL IN LIVER TRANSPLANT PATIENTS WITH RECURRENT HEPATITIS C INFECTION
    Veldt, B. J.
    Poterucha, J. J.
    Watt, K. D. S.
    Weisner, R. H.
    Hay, J. E.
    Kremers, W. K.
    Rosen, C. B.
    Heimbach, J. K.
    Charlton, M. R.
    LIVER TRANSPLANTATION, 2008, 14 (07) : S183 - S183
  • [38] Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection
    Veldt, B. J.
    Poterucha, J. J.
    Watt, K. D. S.
    Wiesner, R. H.
    Hay, J. E.
    Kremers, W. K.
    Rosen, C. B.
    Heimbach, J. K.
    Charlton, M. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (11) : 2426 - 2433
  • [39] Pegylated interferon (PEG-IFN) α-2b+ribavirin (RB) in the treatment of post-liver transplant (LT) recurrent hepatitis C
    Martini, S
    Lavezzo, B
    Saettone, S
    Franchello, A
    Smedile, A
    Cocchis, D
    Ghisetti, V
    David, E
    Salizzoni, M
    Rizzetto, M
    JOURNAL OF HEPATOLOGY, 2005, 42 : 55 - 55
  • [40] Preemptive therapy with combination pegylated interferon and ribavirin in liver transplant recipients with hepatitis C virus
    Neff, GW
    O'Brien, CB
    Safdar, K
    Ruiz, P
    Bejarano, P
    Montalbano, M
    Schiff, ER
    GASTROENTEROLOGY, 2004, 126 (04) : A695 - A695